BiliaryTractCancer near Brooklyn, NY

Biography: Dr. James Cornwall, MD is a General Surgery Specialist who practices in New York, NY. Dr. James Cornwall, MD is affiliated with Mount Sinai Morningside, Mount Sinai Queens and Mount Sinai Brooklyn.

Care Philosophy: One of the most gratifying aspects of practicing at Weill Cornell has been the close collaborations with talented clinicians and scientists in the diagnosis and management of complex blood disorders. In my new role, I look forward to providing the same personal care to my patients utilizing the latest diagnostic tools and therapeutic modalities to improve patient outcomes.

Biography: Dr. Paul Thodiyil, MB BS is a General Surgery Specialist who practices in New York, NY. He is 58 years old and has been practicing for 38 years. Dr. Paul Thodiyil, MB BS is affiliated with Mount Sinai Brooklyn, Mount Sinai Morningside and Mount Sinai Hospital.

Biography: Dr. Nikhil Uppal is an Assistant Professor of Clinical Medicine at Weill Cornell Medical College in the Division of Hematology and Medical Oncology. He is the Site Director for Hematology/Oncology at NewYork-Presbyterian Lower Manhattan Hospital. He has experience with clinical and translational research studies and a special interest in pancreatic malignancies and lymphomas. Dr. Uppal sees patients at both the Weill Cornell Upper East Side and Lower Manhattan Campuses, and is accepting new patients.Dr. Uppal completed his Internal Medicine Residency at the University of Rochester and his Hematology/Oncology fellowship at Strong Memorial University Hospital. Prior to joining Weill Cornell Medicine, Dr. Uppal worked for New York University Langone Arena Oncology. He is a member of the American Society of Clinical Oncology (ASCO) and the American Society of Hematology (ASH).

Care Philosophy: For over a decade I have been taking care of people with lymphoma. At the end of every visit, I want people to know that I have taken the time to develop the plan that is the best for them. I am fortunate to work in a center where cancer care specialists can work along side experts in every field of medicine to care for the whole person. We are working every day to develop better treatments and integrate them into clinical practice. We have been involved in the development of virtually every drug approved for treatment of lymphoma over the past 15 years, including targeted therapies and immunotherapy. In our labs and our clinics we are developing the drugs of the future. We have made a lot of progress in the way lymphoma is diagnosed and treated, and I am determined to continue developing more effective, less toxic therapies.